Shenzhen - Delayed Quote CNY

Landfar Bio-medicine Co., Ltd (000504.SZ)

6.85
+0.20
+(3.01%)
As of 12:33:21 PM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
130,927.52
134,447.80
136,790.92
200,345.46
156,618.31
Cost of Revenue
42,466.05
43,808.01
43,686.45
70,538.09
45,683.42
Gross Profit
88,461.47
90,639.79
93,104.47
129,807.37
110,934.89
Operating Expense
94,631.95
92,673.49
102,157.55
117,609.14
106,934.48
Operating Income
-6,170.48
-2,033.70
-9,053.08
12,198.23
4,000.40
Net Non Operating Interest Income Expense
602.28
238.52
-9,110.55
-11,586.73
-13,988.78
Pretax Income
-24,306.73
-20,851.61
-44,709.70
-21,559.42
-30,227.61
Tax Provision
3,294.40
3,074
2,070.27
7,900.30
2,873.43
Net Income Common Stockholders
-19,294
-19,846.02
-28,172.63
-12,457.38
-19,125.95
Basic EPS
-0.06
-0.06
-0.09
-0.04
-0.06
Diluted EPS
-0.06
-0.06
-0.09
-0.04
-0.06
Basic Average Shares
331,091.83
330,766.97
313,029.17
311,434.49
318,765.84
Diluted Average Shares
331,091.83
330,766.97
313,029.17
311,434.49
318,765.84
Total Operating Income as Reported
-23,892.23
-20,814
-45,714.09
-26,149.34
-30,665.03
Rent Expense Supplemental
1,591.10
--
670.16
805.02
820.90
Total Expenses
137,098
136,481.49
145,844.01
188,147.22
152,617.90
Net Income from Continuing & Discontinued Operation
-19,294
-19,846.02
-28,172.63
-12,457.38
-19,125.95
Normalized Income
-5,952.87
-2,814.81
-6,819.34
7,616.32
-3,736.12
Interest Income
1,902.68
2,026.91
2,346.63
1,776.97
2,461.34
Interest Expense
986.94
1,462.45
10,176.18
11,867.81
14,114.39
Net Interest Income
602.28
238.52
-9,110.55
-11,586.73
-13,988.78
EBIT
-23,319.79
-19,389.16
-34,533.52
-9,691.60
-16,113.22
EBITDA
-23,319.79
-13,679.99
-28,192.26
-3,479.38
-9,241.90
Reconciled Cost of Revenue
42,466.05
43,808.01
43,686.45
70,538.09
45,683.42
Reconciled Depreciation
--
5,709.17
6,341.26
6,212.23
6,871.32
Net Income from Continuing Operation Net Minority Interest
-19,294
-19,846.02
-28,172.63
-12,457.38
-19,125.95
Total Unusual Items Excluding Goodwill
-22,235.21
-22,708.28
-28,471.05
-26,764.93
-20,519.77
Total Unusual Items
-22,235.21
-22,708.28
-28,471.05
-26,764.93
-20,519.77
Normalized EBITDA
-1,084.58
9,028.29
278.79
23,285.55
11,277.87
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-8,894.08
-5,677.07
-7,117.76
-6,691.23
-5,129.94
12/31/2021 - 12/8/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

203400.KQ ABION Inc.
5,840.00
-3.31%
 
7774.T Japan Tissue Engineering Co., Ltd.
602.00
-3.99%
 
344860.KQ INNOGENE Co.,Ltd.
2,115.00
-2.30%
 
130A.T VERITAS IN SILICO INC
636.00
-4.65%
 
475960.KQ TOMOCUBE
19,280.00
-4.55%
 
086900.KQ Medy-Tox Inc.
169,400.00
-6.56%
 
CONCORDBIO.BO Concord Biotech Limited
1,523.55
-1.05%
 
347850.KQ D&D Pharmatech
71,400.00
-2.73%
 
4565.T Nxera Pharma Co., Ltd.
852.00
-2.74%
 
302440.KS SK bioscience Co.,Ltd.
39,500.00
-1.98%